Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/68973
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
LONG COVID: A GLOBAL HEALTH ISSUE: A PROSPECTIVE, COHORT STUDY SET IN FOUR CONTINENTS
Author
Pazukhina, Ekaterina
Garcia-Gallo, Esteban
Reyes, Luis Felipe
Kildal, Anders Benjamin
Jassat, Waasila
Dryden, Murray
Holter, Jan Cato
Chatterjee, Allegra
Gomez, Kyle
Søraas, Arne
Puntoni, Matteo
Latronico, Nicola
Bozza, Fernando A.
Edelstein, Michael
Gonçalves, Bronner P.
Kartsonaki, Christiana
Kruglova, Oksana
Gaião, Sérgio
Chow, Yock Ping
Doshi, Yash
Vallejo, Sara Isabel Duque
Ibáñez-Prada, Elsa D.
Fuentes, Yuli V.
Hastie, Claire
O'Hara, Margaret E.
Balan, Valeria
Menkir, Tigist
Merson, Laura
Kelly, Sadie
Citarella, Barbara Wanjiru
Semple, Malcolm G.
Scott, Janet T.
Munblit, Daniel
Sigfrid, Louise
Garcia-Gallo, Esteban
Reyes, Luis Felipe
Kildal, Anders Benjamin
Jassat, Waasila
Dryden, Murray
Holter, Jan Cato
Chatterjee, Allegra
Gomez, Kyle
Søraas, Arne
Puntoni, Matteo
Latronico, Nicola
Bozza, Fernando A.
Edelstein, Michael
Gonçalves, Bronner P.
Kartsonaki, Christiana
Kruglova, Oksana
Gaião, Sérgio
Chow, Yock Ping
Doshi, Yash
Vallejo, Sara Isabel Duque
Ibáñez-Prada, Elsa D.
Fuentes, Yuli V.
Hastie, Claire
O'Hara, Margaret E.
Balan, Valeria
Menkir, Tigist
Merson, Laura
Kelly, Sadie
Citarella, Barbara Wanjiru
Semple, Malcolm G.
Scott, Janet T.
Munblit, Daniel
Sigfrid, Louise
Affilliation
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
Universidad de La Sabana. School of Medicine. Unisabana Center for Translational Science. Chia, Colombia / Universidad de La Sabana. Clinica. Chia, Colombia.
University Hospital of North Norway. Department of Anesthesiology and Intensive Care. Tromso, Troms, Norway / UiT The Arctic University of Norway. Faculty of Health Sciences. Department of Clinical Medicine. Tromso, Troms, Norway.
Genesis Analytics Pty Ltd. Johannesburg, Gauteng, South Africa / National Institute for Communicable Diseases. Johannesburg, South Africa.
National Institute for Communicable Diseases. Johannesburg, South Africa.
Oslo University Hospital. Department of Microbiology. Oslo, Norway / University of Oslo. Institute of Clinical Medicine. Oslo, Norway.
UK Health Security Agency. London, UK.
Gibraltar Health Authority. Gibraltar, Gibraltar.
The Norwegian Corona Cohort. Oslo, Norway.
University Hospital of Parma. Clinical & Epidemiological Research Unit. Parma, Italy.
University of Brescia. Radiological Sciences and Public Health. Department of Medical and Surgical Specialties. Brescia, Italy / Spedali Civili University Hospital. Department of Emergency. Brescia, Italy.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Medicina Intensiva. Rio de Janeiro, RJ, Brasil / D'Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
Bar-Ilan University The Azrieli Faculty of Medicine. Safed, Northern District, Israel.
University of Surrey. Department of Comparative Biomedical Sciences. Guildford, UK.
University of Oxford. Nuffield Department of Population Health. Oxford, UK.
Lugansk State Medical University. Department of Internal Medicine No 2. Rivne, Ukraine.
São João Hospital Centre. Porto, Portugal.
Sunway Medical Centre. Bandar Sunway, Selangor, Malaysia.
Terna Specialty Hospital and Research Centre. Mumbai, India.
University of Oxford Nuffield Department of Medicine. Oxford, UK.
Universidad de La Sabana. Chia, Colombia.
Universidad de La Sabana. Chia, Colombia.
Long COVID Support. London, UK.
Long COVID Support. London, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
Harvard University. Harvard TH Chan School of Public Health. Department of Epidemiology. The Center for Communicable Disease Dynamics. Oxford, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
University of Oxford. Pandemic Sciences Institute. Oxford, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
University of Liverpool. Veterinary, and Ecological Sciences. Institute of Infection. NIHR Health Protection Research Unit in Emerging and Zoonotic Infections. Liverpool, UK / Liverpool Institute for Child Health and Wellbeing. Alder Hey Children's Hospital. Liverpool, UK.
University of Glasgow. University of Glasgow Centre for Virus Research. MRC. Glasgow, UK / RD&I and COVID Recovery Service. NHS Highland. Inverness, UK.
King's College London. Midwifery and Palliative Care. Florence Nightingale Faculty of Nursing. Division of Care in Long Term Conditions. London, UK / I M Sechenov First Moscow State Medical University. Institute of Child's Health. Department of Paediatrics and Paediatric Infectious Diseases. Moskva, Moskva, Russian Federation.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
Universidad de La Sabana. School of Medicine. Unisabana Center for Translational Science. Chia, Colombia / Universidad de La Sabana. Clinica. Chia, Colombia.
University Hospital of North Norway. Department of Anesthesiology and Intensive Care. Tromso, Troms, Norway / UiT The Arctic University of Norway. Faculty of Health Sciences. Department of Clinical Medicine. Tromso, Troms, Norway.
Genesis Analytics Pty Ltd. Johannesburg, Gauteng, South Africa / National Institute for Communicable Diseases. Johannesburg, South Africa.
National Institute for Communicable Diseases. Johannesburg, South Africa.
Oslo University Hospital. Department of Microbiology. Oslo, Norway / University of Oslo. Institute of Clinical Medicine. Oslo, Norway.
UK Health Security Agency. London, UK.
Gibraltar Health Authority. Gibraltar, Gibraltar.
The Norwegian Corona Cohort. Oslo, Norway.
University Hospital of Parma. Clinical & Epidemiological Research Unit. Parma, Italy.
University of Brescia. Radiological Sciences and Public Health. Department of Medical and Surgical Specialties. Brescia, Italy / Spedali Civili University Hospital. Department of Emergency. Brescia, Italy.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Medicina Intensiva. Rio de Janeiro, RJ, Brasil / D'Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
Bar-Ilan University The Azrieli Faculty of Medicine. Safed, Northern District, Israel.
University of Surrey. Department of Comparative Biomedical Sciences. Guildford, UK.
University of Oxford. Nuffield Department of Population Health. Oxford, UK.
Lugansk State Medical University. Department of Internal Medicine No 2. Rivne, Ukraine.
São João Hospital Centre. Porto, Portugal.
Sunway Medical Centre. Bandar Sunway, Selangor, Malaysia.
Terna Specialty Hospital and Research Centre. Mumbai, India.
University of Oxford Nuffield Department of Medicine. Oxford, UK.
Universidad de La Sabana. Chia, Colombia.
Universidad de La Sabana. Chia, Colombia.
Long COVID Support. London, UK.
Long COVID Support. London, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
Harvard University. Harvard TH Chan School of Public Health. Department of Epidemiology. The Center for Communicable Disease Dynamics. Oxford, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
University of Oxford. Pandemic Sciences Institute. Oxford, UK.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
University of Liverpool. Veterinary, and Ecological Sciences. Institute of Infection. NIHR Health Protection Research Unit in Emerging and Zoonotic Infections. Liverpool, UK / Liverpool Institute for Child Health and Wellbeing. Alder Hey Children's Hospital. Liverpool, UK.
University of Glasgow. University of Glasgow Centre for Virus Research. MRC. Glasgow, UK / RD&I and COVID Recovery Service. NHS Highland. Inverness, UK.
King's College London. Midwifery and Palliative Care. Florence Nightingale Faculty of Nursing. Division of Care in Long Term Conditions. London, UK / I M Sechenov First Moscow State Medical University. Institute of Child's Health. Department of Paediatrics and Paediatric Infectious Diseases. Moskva, Moskva, Russian Federation.
University of Oxford. Nuffield Department of Medicine. Pandemic Sciences Institute. ISARIC Global Support Centre. Oxford, UK.
Abstract
Introduction: A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to characterise long-term COVID-19 sequelae in populations globally and compare the prevalence of reported symptoms in HICs and low-income and middle-income countries (LMICs). Methods: A prospective, observational study in 17 countries in Africa, Asia, Europe and South America, including adults with confirmed COVID-19 assessed at 2 to <6 and 6 to <12 months post-hospital discharge. A standardised case report form developed by International Severe Acute Respiratory and emerging Infection Consortium's Global COVID-19 Follow-up working group evaluated the frequency of fever, persistent symptoms, breathlessness (MRC dyspnoea scale), fatigue and impact on daily activities. Results: Of 11 860 participants (median age: 52 (IQR: 41-62) years; 52.1% females), 56.5% were from HICs and 43.5% were from LMICs. The proportion identified with Long Covid was significantly higher in HICs vs LMICs at both assessment time points (69.0% vs 45.3%, p<0.001; 69.7% vs 42.4%, p<0.001). Participants in HICs were more likely to report not feeling fully recovered (54.3% vs 18.0%, p<0.001; 56.8% vs 40.1%, p<0.001), fatigue (42.9% vs 27.9%, p<0.001; 41.6% vs 27.9%, p<0.001), new/persistent fever (19.6% vs 2.1%, p<0.001; 20.3% vs 2.0%, p<0.001) and have a higher prevalence of anxiety/depression and impact on usual activities compared with participants in LMICs at 2 to <6 and 6 to <12 months post-COVID-19 hospital discharge, respectively. Conclusion: Our data show that Long Covid affects populations globally, manifesting similar symptomatology and impact on functioning in both HIC and LMICs. The prevalence was higher in HICs versus LMICs. Although we identified a lower prevalence, the impact of Long Covid may be greater in LMICs if there is a lack of support systems available in HICs. Further research into the aetiology of Long Covid and the burden in LMICs is critical to implement effective, accessible treatment and support strategies to improve COVID-19 outcomes for all.
Share